Susquehanna International Group’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Susquehanna International Group’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,482	Closed	-$158K	–	13734
2023 Q3	$158K	Buy	15,482 +1,099	+8%	+$8.37K	﹤0.01%	10497
2023 Q2	$67.6K	Sell	14,383 -3,361	-19%	-$15.4K	﹤0.01%	11202
2023 Q1	$82K	Buy	+17,744	New	+$78.1K	﹤0.01%	11422
2022 Q4	–	Sell	-10,646	Closed	-$50K	–	14167
2022 Q3	$50K	Sell	10,646 -7,848	-42%	-$39.4K	﹤0.01%	12209
2022 Q2	$90K	Buy	+18,494	New	+$112K	﹤0.01%	11568

Susquehanna International Group's THRN Position: Q4 2023 in Review

Susquehanna International Group sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 15,482 shares — an estimated $158K sold.

Susquehanna International Group first reported a position in THRN in Q2 2022 and held it in 5 quarters. The position peaked at $158K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Susquehanna International Group reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Susquehanna International Group sold 15,482 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $158K.
Susquehanna International Group first reported a position in Thorne Healthtech, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Susquehanna International Group's Thorne Healthtech, Inc. Common Stock position peaked at $158K in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.